Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Influenza Vaccines"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 70009
Tytuł:
Downregulation of hypocretin/orexin after H1N1 Pandemrix vaccination of adolescent mice.
Autorzy:
Pagh-Berendtsen N; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Pavlovskyi A; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Flores Téllez D; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Egebjerg C; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Kolmos MG; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Justinussen J; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Kornum BR; Faculty of Health and Medical Sciences, Department of Neuroscience, University of Copenhagen, Denmark.
Pokaż więcej
Źródło:
Sleep [Sleep] 2024 Apr 12; Vol. 47 (4).
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza, Human*
Influenza Vaccines*/adverse effects
Narcolepsy*/chemically induced
Narcolepsy*/diagnosis
Child ; Humans ; Adolescent ; Mice ; Animals ; Adult ; Orexins/genetics ; Orexins/metabolism ; Down-Regulation ; Vaccination/adverse effects ; RNA, Messenger
Czasopismo naukowe
Szczegóły
Tytuł:
Estradiol mediates greater germinal center responses to influenza vaccination in female than male mice.
Autorzy:
Dhakal S; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Park H-S; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Seddu K; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Lee JS; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Creisher PS; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Seibert B; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Davis KM; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Hernandez IR; Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Maul RW; Laboratory of Molecular Biology and Immunology, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Apr 10; Vol. 15 (4), pp. e0032624. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
Male ; Animals ; Mice ; Female ; Humans ; Estradiol ; Antibodies, Viral ; Germinal Center ; Vaccination ; Mice, Transgenic ; Vaccines, Inactivated ; Antiviral Agents
Czasopismo naukowe
Szczegóły
Tytuł:
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024.
Autorzy:
Gu X; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Watson C; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Agrawal U; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Whitaker H; Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom.
Elson WH; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Anand S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Borrow R; Vaccine Evaluation Unit, UK Health Security Agency, Manchester, United Kingdom.
Buckingham A; NHS England, London, United Kingdom.
Button E; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Curtis L; Royal College of General Practitioners, London, United Kingdom.
Dunn D; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Elliot AJ; Real-time Syndromic Surveillance Team, UK Health Security Agency, Birmingham, United Kingdom.
Ferreira F; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Goudie R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Hoang U; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Hoschler K; Respiratory Virus Unit, UK Health Security Agency, London, United Kingdom.
Jamie G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Kar D; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Kele B; Respiratory Virus Unit, UK Health Security Agency, London, United Kingdom.
Leston M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Linley E; Vaccine Evaluation Unit, UK Health Security Agency, Manchester, United Kingdom.
Macartney J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Marsden GL; Royal College of General Practitioners, London, United Kingdom.
Okusi C; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Parvizi O; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Respiratory Virus Unit, UK Health Security Agency, London, United Kingdom.
Quinot C; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Sebastianpillai P; Virus Reference Department, UK Health Security Agency, London, United Kingdom.
Sexton V; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Smith G; Real-time Syndromic Surveillance Team, UK Health Security Agency, Birmingham, United Kingdom.
Suli T; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Thomas NPB; Royal College of General Practitioners, London, United Kingdom.
Thompson C; Respiratory Virus Unit, UK Health Security Agency, London, United Kingdom.
Todkill D; Real-time Syndromic Surveillance Team, UK Health Security Agency, Birmingham, United Kingdom.
Wimalaratna R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Inada-Kim M; NHS England, London, United Kingdom.
Andrews N; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
Tzortziou-Brown V; Royal College of General Practitioners, London, United Kingdom.
Byford R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Zambon M; Virus Reference Department, UK Health Security Agency, London, United Kingdom.
Lopez-Bernal J; Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło:
JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Apr 03; Vol. 10, pp. e52047. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Virus Diseases*
COVID-19*
Respiratory Tract Infections*/epidemiology
Humans ; Sentinel Surveillance ; World Health Organization ; Primary Health Care
Czasopismo naukowe
Szczegóły
Tytuł:
Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial.
Autorzy:
Yadegarynia D; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Keyvanfar A; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: .
Keyvani H; Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Tehrani S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sali S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abolghasemi S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2254-2259. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Influenza Vaccines*/adverse effects
Influenza A Virus, H1N1 Subtype*
HIV Seropositivity*
Influenza, Human*/prevention & control
Humans ; Iran ; Influenza A Virus, H3N2 Subtype ; Antibodies, Viral ; Volunteers ; Vaccines, Inactivated ; Double-Blind Method ; Hemagglutination Inhibition Tests ; Vaccines, Combined ; Immunogenicity, Vaccine
Czasopismo naukowe
Szczegóły
Tytuł:
Influenza vaccination in pregnant women in Iceland 2010-2020 and the burden of influenza in pregnant women and their infants.
Autorzy:
Kristinsdottir I; Faculty of Medicine, University of Iceland, Iceland; Children's Hospital Iceland, Landspitali University Hospital, Iceland.
Haraldsson A; Faculty of Medicine, University of Iceland, Iceland; Children's Hospital Iceland, Landspitali University Hospital, Iceland.
Thors V; Faculty of Medicine, University of Iceland, Iceland; Children's Hospital Iceland, Landspitali University Hospital, Iceland. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Mar 19; Vol. 42 (8), pp. 2051-2058. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Pregnancy Complications, Infectious*/epidemiology
Pregnancy Complications, Infectious*/prevention & control
Infant ; Humans ; Female ; Pregnancy ; Infant, Newborn ; Child, Preschool ; Child ; Adolescent ; Pregnant Women ; Retrospective Studies ; Iceland/epidemiology ; Vaccination ; Seasons
Czasopismo naukowe
Szczegóły
Tytuł:
Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
Autorzy:
Li H; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Sun H; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.; Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China.; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Tao M; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Han Q; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Yu H; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Li J; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Lu X; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Tong Q; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Pu J; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Sun Y; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Liu L; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Liu J; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Sun H; National Key Laboratory of Veterinary Public Health and Safety, Key Laboratory for Prevention and Control of Avian Influenza and Other Major Poultry Diseases, Ministry of Agriculture and Rural Affairs, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Pokaż więcej
Źródło:
Journal of virology [J Virol] 2024 Mar 19; Vol. 98 (3), pp. e0112923. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H5N1 Subtype*/chemistry
Influenza A Virus, H5N1 Subtype*/classification
Influenza A Virus, H5N1 Subtype*/genetics
Influenza A Virus, H5N1 Subtype*/immunology
Influenza A Virus, H5N6 Subtype*/chemistry
Influenza A Virus, H5N6 Subtype*/classification
Influenza A Virus, H5N6 Subtype*/genetics
Influenza A Virus, H5N6 Subtype*/immunology
Influenza Vaccines*/administration & dosage
Influenza Vaccines*/adverse effects
Influenza Vaccines*/genetics
Influenza Vaccines*/immunology
Orthomyxoviridae Infections*/immunology
Orthomyxoviridae Infections*/prevention & control
Orthomyxoviridae Infections*/transmission
Orthomyxoviridae Infections*/virology
Parainfluenza Virus 5*/genetics
Parainfluenza Virus 5*/immunology
Parainfluenza Virus 5*/metabolism
Animals ; Humans ; Mice ; Ferrets/immunology ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Immunity, Cellular ; Immunity, Humoral ; Immunity, Mucosal ; Influenza in Birds/immunology ; Influenza in Birds/prevention & control ; Influenza in Birds/transmission ; Influenza in Birds/virology ; Pandemic Preparedness/methods ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/genetics ; Vaccines, Synthetic/immunology ; Administration, Intranasal ; Poultry/virology ; Immunoglobulin A/immunology ; T-Lymphocytes/immunology
Czasopismo naukowe
Szczegóły
Tytuł:
Insights from Avian Influenza: A Review of Its Multifaceted Nature and Future Pandemic Preparedness.
Autorzy:
He J; Division of Natural and Applied Science, Duke Kunshan University, No. 8 Duke Avenue, Kunshan 215316, China.
Kam YW; Division of Natural and Applied Science, Duke Kunshan University, No. 8 Duke Avenue, Kunshan 215316, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 17; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Influenza in Birds*/epidemiology
Influenza in Birds*/prevention & control
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Influenza A virus*/genetics
Animals ; Humans ; Pandemic Preparedness ; Pandemics/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness of influenza vaccine in preventing severe cases of influenza: Season 2022/2023.
Autorzy:
Platas-Abenza G; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Guerrero-Soler M; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Silva-Afonso RF; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Gallardo-Rodriguez P; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Gil-Sánchez F; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Escribano-Cañadas I; Servicio de Microbiología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Benito-Miralles CM; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Solis-Aniorte N; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Carnicer-Bueno R; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Esclapez-Martínez A; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Chico-Sánchez P; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Electronic address: .
Sánchez-Payá J; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Gras-Valentí P; Unidad de Epidemiología, Servicio de Medicina Preventiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
Pokaż więcej
Źródło:
Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2024 Mar; Vol. 42 (3), pp. 140-145. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Male ; Humans ; Female ; Case-Control Studies ; Seasons ; Vaccination
Czasopismo naukowe
Szczegóły
Tytuł:
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.
Autorzy:
Bean R; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Giurgea LT; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Han A; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Czajkowski L; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Cervantes-Medina A; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Gouzoulis M; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Mateja A; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Hunsberger S; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Reed S; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Athota R; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Baus HA; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kash JC; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Park J; Department of Veterinary Medicine, VA-MD College of Veterinary Medicine, University of Maryland, College Park, Maryland, USA.
Taubenberger JK; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Memoli MJ; LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2024 Feb 14; Vol. 15 (2), pp. e0237223. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Orthomyxoviridae Infections*
Humans ; Hemagglutinins ; Healthy Volunteers ; Antibodies, Viral ; Nasal Mucosa ; Vaccines, Inactivated ; Neuraminidase ; Immunoglobulin G ; Hemagglutinin Glycoproteins, Influenza Virus
Czasopismo naukowe
Szczegóły
Tytuł:
Frequency of Asthma Exacerbations and Upper Respiratory Tract Infections Among Adults With Asthma According to Vaccination Status: Does the annual influenza vaccine have a protective effect?
Autorzy:
Kharusi ZA; Family Medicine, Directorate-General of Primary Healthcare, Ministry of Health, Muscat, Oman.
Kalbani RA; Family Medicine, Directorate-General of Primary Healthcare, Ministry of Health, Muscat, Oman.
Al-Hadhrami R; Department of Family Medicine & Public Health, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.
Pokaż więcej
Źródło:
Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 Feb; Vol. 24 (1), pp. 70-75. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/complications
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Respiratory Tract Infections*/epidemiology
Respiratory Tract Infections*/prevention & control
Asthma*/complications
Asthma*/epidemiology
Adult ; Humans ; Female ; Male ; Retrospective Studies ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sense of community belonging and influenza vaccine uptake in Canada.
Autorzy:
Kwok YCK; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. .
Brooks JD; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Buchan SA; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Public Health Ontario, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Canadian journal of public health = Revue canadienne de sante publique [Can J Public Health] 2024 Feb; Vol. 115 (1), pp. 69-79. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
North American People*
Female ; Humans ; Canada/epidemiology ; Social Cohesion ; Vaccination ; Male ; Adolescent ; Young Adult ; Adult ; Middle Aged
Czasopismo naukowe
Szczegóły
Tytuł:
[Efficacy and safety of pediatric flu vaccination: a systematic review].
Autorzy:
Escandell Rico FM; Francisco Miguel Escandell Rico, Departamento de enfermería. Universidad de Alicante. Cl Villanº24 Crevillente, Alicante (España). .
Pérez Fernández L
Pokaż więcej
Transliterated Title:
Eficacia y seguridad de la vacunación antigripal pediátrica: una revisión sistemática.
Źródło:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2024 Feb; Vol. 37 (1), pp. 43-51. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
English Abstract; Systematic Review
MeSH Terms:
Influenza, Human*/prevention & control
Influenza, Human*/epidemiology
Influenza Vaccines*/adverse effects
Adolescent ; Child ; Humans ; Systematic Reviews as Topic ; Vaccination/adverse effects
Szczegóły
Tytuł:
Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.
Autorzy:
Chen G; Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.
Han Q; Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.
Li WX; Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.
Hai R; Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.
Ding SW; Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.
Pokaż więcej
Źródło:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Apr 23; Vol. 121 (17), pp. e2321170121. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:
Journal Article
MeSH Terms:
Viral Vaccines*
Viruses*
Influenza Vaccines*
Animals ; Humans ; Mice ; T-Lymphocytes ; RNA Interference ; Vaccines, Attenuated ; Homeodomain Proteins ; Antibodies, Viral
Czasopismo naukowe
Szczegóły
Tytuł:
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients.
Autorzy:
Amarin JZ; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.; Epidemiology Doctoral Program, School of Medicine, Vanderbilt University, Nashville, TN.
Dulek DE; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Simmons J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Hayek H; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Chappell JD; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Nochowicz CH; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Kitko CL; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Schuster JE; Department of Pediatrics, Children's Mercy Kansas City, Kansas City, MO.
Muñoz FM; Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.; Department of Molecular Virology and Microbiology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Bocchini CE; Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Moulton EA; Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
Coffin SE; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Freedman JL; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Ardura MI; Division of Infectious Diseases and Host Defense Program, Nationwide Children's Hospital, Columbus, OH.; Department of Pediatrics, The Ohio State University, Columbus, OH.
Wattier RL; Department of Pediatrics, University of California San Francisco and Benioff Children's Hospital, San Francisco, CA.
Maron G; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN.
Grimley M; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Paulsen G; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Danziger-Isakov L; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Carpenter PA; Department of Pediatrics, University of Washington and Seattle Children's Research Institute, Seattle, WA.
Englund JA; Department of Pediatrics, University of Washington and Seattle Children's Research Institute, Seattle, WA.
Halasa NB; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
Spieker AJ; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
Kalams SA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN.
Pokaż więcej
Źródło:
Blood advances [Blood Adv] 2024 Apr 23; Vol. 8 (8), pp. 1880-1892.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Hematopoietic Stem Cell Transplantation*
Influenza A Virus, H1N1 Subtype*
Humans ; Child ; Transplant Recipients ; Immunogenicity, Vaccine ; Influenza A Virus, H3N2 Subtype ; Leukocytes, Mononuclear
Czasopismo naukowe
Szczegóły
Tytuł:
Influenza vaccination accuracy among adults: Self-report compared with electronic health record data.
Autorzy:
Daley MF; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: .
Reifler LM; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA. Electronic address: .
Shoup JA; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA. Electronic address: .
Glanz JM; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA. Electronic address: .
Lewin BJ; Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. Electronic address: .
Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, USA. Electronic address: .
Kharbanda EO; HealthPartners Institute, Minneapolis, MN, USA. Electronic address: .
McLean HQ; Marshfield Clinic Research Institute, Marshfield, WI, USA. Electronic address: .
Hambidge SJ; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA; Department of Ambulatory Care Services, Denver Health and Hospitals, Denver, CO, USA. Electronic address: .
Nelson JC; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. Electronic address: .
Naleway AL; Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA. Electronic address: .
Weintraub ES; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
McNeil MM; Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Razzaghi H; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Singleton JA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Apr 19; Vol. 42 (11), pp. 2740-2746. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Adult ; Humans ; Electronic Health Records ; Self Report ; Vaccination ; Surveys and Questionnaires ; Seasons
Czasopismo naukowe
Szczegóły
Tytuł:
Higher educational attainment associated with higher confidence in influenza vaccination in Norway.
Autorzy:
Klüwer B; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222, Skøyen, N-0213 Oslo, Norway. Electronic address: .
Gleditsch R; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222, Skøyen, N-0213 Oslo, Norway. Electronic address: .
Rydland KM; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222, Skøyen, N-0213 Oslo, Norway. Electronic address: .
Mamelund SE; Centre for Research on Pandemics & Society, Oslo Metropolitan University, Senter for velferds- og arbeidslivsforskning, OsloMet - storbyuniversitetet, Postboks 4, St. Olavs plass, 0130 Oslo, Norway. Electronic address: .
Laake I; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222, Skøyen, N-0213 Oslo, Norway. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Apr 19; Vol. 42 (11), pp. 2837-2847. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Influenza, Human*
Humans ; Vaccination ; Norway ; Educational Status ; Seasons
Czasopismo naukowe
Szczegóły
Tytuł:
High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs.
Autorzy:
Price O; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia. Electronic address: .
Dietze P; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia; Disease Elimination Program, Burnet Institute, Melbourne, Australia; National Drug Research Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Maher L; Kirby Institute, UNSW Sydney, Sydney, Australia.
Dore GJ; Kirby Institute, UNSW Sydney, Sydney, Australia.
Sutherland R; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Salom C; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia; Institute for Social Science Research, University of Queensland, Brisbane, Australia.
Bruno R; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia; School of Psychological Science, University of Tasmania, Hobart, Australia.
Crawford S; Harm Reduction Victoria, Melbourne, Australia.
Degenhardt L; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Larney S; Department of Family Medicine and Emergency Medicine, Universite de Montreal, Montreal, Canada; Centre de Recherche du CHUM, Montreal, Canada.
Peacock A; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Apr 19; Vol. 42 (11), pp. 2877-2885. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Influenza Vaccines*
Humans ; Male ; Middle Aged ; Female ; COVID-19 Vaccines ; Australia/epidemiology ; Vaccination
Czasopismo naukowe
Szczegóły
Tytuł:
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge.
Autorzy:
Hill-Batorski L; FluGen, Inc., Madison, WI, USA.
Bowen R; Colorado State University, Fort Collins, CO, USA.
Bielefeldt-Ohmann H; University of Queensland, Brisbane, QLD, Australia.
Moser MJ; FluGen, Inc., Madison, WI, USA.
Matejka SM; FluGen, Inc., Madison, WI, USA.
Marshall D; FluGen, Inc., Madison, WI, USA.
Kawaoka Y; University of Wisconsin, Madison, WI, USA.
Neumann G; University of Wisconsin, Madison, WI, USA.
Bilsel P; FluGen, Inc., Madison, WI, USA. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2024 Apr 19; Vol. 42 (11), pp. 2770-2780. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza, Human*/prevention & control
Influenza Vaccines*
Orthomyxoviridae Infections*/prevention & control
COVID-19*/prevention & control
Humans ; Cricetinae ; COVID-19 Vaccines ; SARS-CoV-2 ; Influenza A Virus, H3N2 Subtype ; Pandemics/prevention & control ; Antibodies, Viral ; Vaccination ; Antibodies, Neutralizing ; Adjuvants, Immunologic
Czasopismo naukowe
Szczegóły
Tytuł:
Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children.
Autorzy:
Jia JZ; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Cohen CA; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Gu H; Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
McLean MR; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
Varadarajan R; Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Bhandari N; Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Peiris M; Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.; Centre for Immunology and Infection (C2i), Hong Kong Science and Technology Park, Hong Kong, SAR, China.
Leung GM; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.; Laboratory of Data Discovery for Health Limited, Hong Kong Science and Technology Park, Hong Kong, SAR, China.
Poon LLM; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.; Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.; Centre for Immunology and Infection (C2i), Hong Kong Science and Technology Park, Hong Kong, SAR, China.
Tsang T; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
Cowling BJ; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Leung NHL; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Valkenburg SA; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China. .; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Apr 13; Vol. 15 (1), pp. 3210. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines*
Child ; Humans ; Prospective Studies ; Antibodies, Viral ; Antibodies, Neutralizing ; Immunoglobulin G
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of health education on promoting influenza vaccination health literacy in primary school students: a cluster randomised controlled trial protocol.
Autorzy:
Xie W; Center for Disease Control and Prevention of Dongguan City, Dongguan, Guangdong Province, China.
Xiao J; Sun Yat-Sen University, Guangzhou, China.
Chen J; Sun Yat-Sen University, Guangzhou, China.
Huang H; Center for Disease Control and Prevention of Dongguan City, Dongguan, Guangdong Province, China.
Huang X; Center for Disease Control and Prevention of Dongguan City, Dongguan, Guangdong Province, China.
He S; Sun Yat-Sen University, Guangzhou, China.
Xu L; Sun Yat-Sen University, Guangzhou, China .
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2024 Apr 12; Vol. 14 (4), pp. e080115. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Health Literacy*
Influenza, Human*/prevention & control
Influenza Vaccines*/therapeutic use
Humans ; Vaccination ; Health Education ; Schools ; Self Report ; Students ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 70009

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies